What is XERS's P/E ratio?

XERIS PHARMACEUTICALS INC (XERS) currently trades at a P/E ratio of 76.19.

XERIS PHARMACEUTICALS INC reports a Return on Equity (ROE) of 92.29%.

What is XERS's dividend yield?

XERIS PHARMACEUTICALS INC offers a dividend yield of 0.00%.

What is XERS's Deepscope Quality Score?

Deepscope rates XERS's overall financial quality at 69 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy XERS?

Deepscope's AI Timing Score for XERS is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does XERS belong to?

XERIS PHARMACEUTICALS INC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.

หุ้น XERS (NASDAQ) | XERIS PHARMACEUTICALS INC – วิเคราะห์โดย Deepscope

Stock Check ข้อมูลอัปเดตรายวัน ที่เวลา 09.30 น.
(Price: 2026-06-05 | FS: 2026-03-31)

XERS

XERIS PHARMACEUTICALS INC

USD 6.18

0.03 (0.49%) Day Change

Watchlist Portfolio Compare Chart

76.19

P/E

17.48

D/E

92.3%

ROE

3.1%

ROA

0.00%

Div Yield

-1.49

PEG

XERIS PHARMACEUTICALS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 6.18 Price 0.03 (0.49%) Day Change	NEWS SCORE: 93

XERS มีคุณภาพโดยรวมพอใช้ ( คะแนนปัจจัยพื้นฐาน = 69) และ จังหวะเข้าซื้อ ...(ล็อกอินเพื่อดู)...

Loading chart...

69 QUALITY

Signal: NEUTRAL

Signal Description: Company financial health is OK

Reason: P/E ratio ค่อนข้างสูง
อัตราการเติบโตของอัตราผลตอบแทนผู้ถือหุ้น (ROE) ในปีก่อน เป็นลบ
อัตราผลตอบแทนสินทรัพย์ (ROA) ค่อนข้างต่ำเมื่อเทียบกับอัตราผลตอบแทนผู้ถือหุ้น(ROE)
อัตรากำไรสุทธิ ค่อนข้างต่ำ
อัตรากำไรสุทธิในอดีต ค่อนข้างต่ำ

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

ถ้าดูอย่างละเอียดจะพบว่า ปัจจัยทางคุณภาพ ยังไม่ดีนัก สุขภาพทางการเงิน ไม่ดี และ ประสิทธิภาพการทำกำไร ยังไม่ดีนัก , ...

ปัจจัยทางคุณภาพ

58%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	93
Magic Formula Rank by ROA	3104
Magic Formula Rank by ROE	3104
Magic Formula Rank by ROIC	3111
Price	6.18
PBV / Sector	81.60 / 2.76
Earning Per Share	0.07

PE / Sector	76.19 / 23.64
PEG or PE/Growth / Sector	-1.49 / 0.13
Average 1M Daily Value	9.27 M
Average 1W Daily Value	7.98 M

ปัจจัยทางเทคนิค

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

สุขภาพทางการเงิน

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ประสิทธิภาพการทำกำไร

58%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	3.81 / 15.98
NPM Average (%) / Sector	-29.37 / -16.38
NPM Change Average (%) / Sector	430.94 / 113.39 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	3.06 / 8.16
ROA Average (%) / Sector	-12.11 / 2.38
ROA Change Average (%) / Sector	469.48 / 108.63 GREAT
ROE (%) / Sector	92.29 / -0.19 GREAT
ROE Average (%) / Sector	197.99 / 7.40 GREAT
ROE Change Average (%) / Sector	366.16 / 371.95 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

ผลตอบแทนต่อผู้ถือหุ้น

Dividend (%) / Sector	N/A / 0.53
Dividend Average (%) / Sector	N/A / 3.08
Dividend Change Average (%) / Sector	N/A / 14.88

รายละเอียดการจดทะเบียน

Analyze Date	2026-06-06 09:09:19
Symbol	XERS
Name	XERIS PHARMACEUTICALS INC
Sector	Healthcare >> Drug Manufacturers - Specialty & Generic
Market	NASDAQ
Listed Shares	172.64 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,061.75 / 9,835.56

ข่าว, ประมาณการ, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1375 West Fulton Street, Chicago, IL, United States, 60607

Phone: 844 445 5704

Website: https://www.xerispharma.com

Employees: 435

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.